Ticker
UK approves Oxford/AstraZeneca Covid vaccine
By EUobserver
The UK medicines regulator has approved the Oxford/AstraZeneca vaccine against Covid-19 on Wednesday, which is geared towards helping the elderly. The UK has ordered 100m doses. Oxford/AstraZeneca had a 62 percent efficacy in their largest trial, of 11,636 people, but 90 percent efficacy in a small additional sub-group in the UK numbering 2,741. The vaccine is easier to transport and store than the one produced by Pfizer/BioNTech.